List view / Grid view

Prasad Lakshmanan Selvaraj (Sannova)

 

article

Beyond ELISA: the future of biomarker validation

27 November 2024 | By

The era of precision medicine demands more rigorous biomarker validation methods. While ELISA has long been the gold standard, advanced technologies such as LC-MS/MS and Meso Scale Discovery (MSD) offer superior precision, sensitivity and efficiency. Here, Prasad Lakshmanan Selvaraj, Director of Technical Review at Sannova, explains that by embracing these…